We are live on ! Find out more
VTGN icon

VistaGen Therapeutics
VTGN

74 hedge funds and large institutions have $227M invested in VistaGen Therapeutics in 2021 Q1 according to their latest regulatory filings, with 32 funds opening new positions, 28 increasing their positions, 5 reducing their positions, and 10 closing their positions.

New
Increased
Maintained
Reduced
Closed

460% more repeat investments, than reductions

Existing positions increased: 28 | Existing positions reduced: 5

220% more first-time investments, than exits

New positions opened: 32 | Existing positions closed: 10

100% more funds holding in top 10

Funds holding in top 10: 1 → 2 (+1)

78% more capital invested

Capital invested by funds: $127M → $227M (+$99.2M)

42% more funds holding

Funds holding: 52 → 74 (+22)

0.83% more ownership

Funds ownership: 1.63% → 2.46% (+0.83%)

Holders
74
Holders Change
+22
Holders Change %
+42.31%
% of All Funds
1.3%
Holding in Top 10
2
Holding in Top 10 Change
+1
Holding in Top 10 Change %
+100%
% of All Funds
0.04%
New
32
Increased
28
Reduced
5
Closed
10
Calls
–
Puts
–
Net Calls
–
Net Calls Change
–

Top Buyers

Rank Fund Capital Flow
1
NMC
NEA Management Company
Maryland
+$15.4M
2
VA
VR Adviser
New York
+$15.4M
3
ACP
Acuta Capital Partners
California
+$10.7M
4
Franklin Resources
Franklin Resources
California
+$10.3M
5
MWNA
Marshall Wace North America
New York
+$6.29M

Top Sellers

Rank Fund Capital Flow
1
ACM
Asymmetry Capital Management
California
-$4.34M
2
IC
Ikarian Capital
Texas
-$3.56M
3
PVI
Pura Vida Investments
New York
-$2.83M
4
GPCM
Granite Point Capital Management
Massachusetts
-$1.88M
5
Renaissance Technologies
Renaissance Technologies
New York
-$1.62M
Name Holding Trade Value Shares
Change 		Change in
Stake
JG
51
Jefferies Group
New York
$61.6K +$64.3K +963 New
FAIM
52
Financial Advocates Investment Management
Washington
$49K – – –
NA
53
NewEdge Advisors
Louisiana
$47K +$6.67K +100 +16%
IAN
54
Integrated Advisors Network
Texas
$47K +$15.6K +233 +47%
CTA
55
Chesley Taft & Associates
Illinois
$46K +$44.5K +667 New
Carson Wealth (CWM LLC)
56
Carson Wealth (CWM LLC)
Nebraska
$43K – – –
GBA
57
Garrison Bradford & Associates
New York
$43K – – –
Barclays
58
Barclays
United Kingdom
$43K +$44.9K +672 New
Jane Street
59
Jane Street
New York
$42K +$44.3K +664 New
AI
60
Atom Investors
Texas
$41K +$42.7K +639 New
Commonwealth Equity Services
61
Commonwealth Equity Services
Massachusetts
$38K +$40.5K +607 New
HFM
62
Hartford Financial Management
Connecticut
$34K – – –
TSS
63
Two Sigma Securities
New York
$27K +$28.7K +430 New
UBS Group
64
UBS Group
Switzerland
$23K -$20.7K -310 -46%
JMPWA
65
JP Morgan Private Wealth Advisors
California
$21K – – –
NAS
66
Nicolet Advisory Services
Wisconsin
$21K – – –
CF
67
Centaurus Financial
California
$21K +$22.2K +333 New
SM
68
Sciencast Management
New Jersey
$21K +$22.2K +333 New
AWM
69
Atticus Wealth Management
Florida
$6K +$6.01K +90 New
IAIM
70
International Assets Investment Management
Florida
$6K +$6.14K +92 New
Wells Fargo
71
Wells Fargo
California
$2K +$1K +15 +107%
NL
72
NVWM LLC
Pennsylvania
$2K +$2.2K +33 New
BC
73
Burleson & Co
California
$1K +$801 +12 New
ACM
74
Asymmetry Capital Management
California
– -$4.34M -74,660 Closed
PVI
75
Pura Vida Investments
New York
– -$2.83M -48,611 Closed
1 2
3
4

VTGN Hedge Fund Activity: Q1 2021 in Review

74 of the 5,695 institutional investors tracked by Wall St. Rank reported a position in VistaGen Therapeutics (VTGN) for Q1 2021, worth a combined $227M — up 78% from $127M a quarter earlier.

Buyers outnumbered sellers: 32 funds opened new VTGN positions and 10 closed out — a net gain of 22 holders — while 28 added to existing stakes and 5 trimmed.

The largest buyer was NEA Management Company, adding an estimated $15.4M. The largest seller was Asymmetry Capital Management, exiting entirely with an estimated $4.34M sold.

  • 74 institutional investors held VistaGen Therapeutics (VTGN) as of Q1 2021, up from 52 in Q4 2020.
  • Funds reported $227M of VistaGen Therapeutics stock for Q1 2021, up 78% quarter-over-quarter.
  • 32 funds opened new VistaGen Therapeutics positions in Q1 2021 and 10 closed out, a net change of +22 holders.
  • The largest VistaGen Therapeutics buyer in Q1 2021 was NEA Management Company, an estimated $15.4M added.
  • The largest VistaGen Therapeutics seller in Q1 2021 was Asymmetry Capital Management, an estimated $4.34M sold.

Based on aggregated 13F filings for Q1 2021.